Overall, these results demonstrate that the diagnostic methylation classifier has a stable classification ability to predict the group membership of NSE, BE, EAC, and ESCC, and can eliminate the possible effect from normal and cancerous tissues of HNSC and STAD. The gene discussed is ENO2; the disease is esophageal squamous cell carcinoma.